No significant differences were observed between the two groups in terms of gender, comorbidities, CKD, smoking status, body mass index (BMI), blood pressure, heart rate, leukocyte count, hsCRP, VEGF, vWF, Tie-2, or Ang-1 levels. This evidence concerns the gene VEGFA and chronic kidney disease.